November 2015 - Bioscience Americas

November 2015

Focusing on Latin America is Essential in 2016

While the attention of the United States is focused elsewhere, Latin America is entering a period of dynamic change that could reshape its future, and recast relations with its neighbor to the north. In Argentina, a notable reformer finds himself in a close election against a member of the old guard. In Venezuela, the ruling party is turning increasingly repressive in an attempt to retain its slipping grip on power. Colombia is trying to reconcile its search for peace [...]

Bioscience Americas Presents at GoDaddy Sponsored VC Event

Bioscience Americas, LLC, a leading international developer of for-profit autologous stem cell wellness centers, is pleased to report than they were among a select group of companies invited to participate in the GoDaddy sponsored Funding Post Venture Capital and Angel Network Investor Roundtable held recently at GoDaddy’s headquarters in Scottsdale, Arizona. Bioscience Americas is the international development partner of the Global Institute of Stem Cell Therapy and Research. Based in San Diego, California at the University of California Medical [...]

Update on Bart Starr’s Stem Cell Treatment

Hall of Fame quarterback Bart Starr recently returned from a second round of stem cell treatments in Mexico. His latest injection is intended to heal his brain and get him ready to make a triumphant return to Green Bay for a Thanksgiving Day game between the Packers and the Chicago Bears. His goal is to walk on the field with former Packers quarterback Brett Favre when Favre's jersey number is retired at halftime on Thanksgiving. The treatment is [...]

Study: Induced Pluripotent Stem Cells Functionally Equivalent To Embryonic

Embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs), reprogrammed from adult differentiated cells, reportedly behaved differently from one another in myriad studies. But these functional differences between cell types may not be as drastic as previously thought, according to a team led by Konrad Hochedlinger of Harvard University, which published its findings Monday (October 26) in Nature Biotechnology. Genetic individuality could explain some differences between human iPSCs and ESCs, the authors proposed. There may be discrepancies when comparing [...]